Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - gemcitabine as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - gemcitabine as hydrochloride 200 mg - gemcitabine - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer. gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - gemcitabine as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - gemcitabine as hydrochloride 1000 mg - gemcitabine - gemcitabine - palliative treatment of patients with locally advanced or metastatic non-small cell lung cancer and locally advanced or metastatic adenocarcinoma of the pancreas and for patients with 5-fu refractory pancreatic cancer.gemcitabine is indicated for the treatment of patients with bladder cancer at the invasive stage. breast cancer: gemcitabine in combination with paclitaxel is indicated for the treatment of patients with unresectable locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemotherapy should have included an anthracycline unless clinically contraindicated. ovarian cancer: gemcitabine in combination with carboplatin is indicated for the treatment of patients with recurrent epithelial ovarian carcinoma whom have relapsed at least six months after platinum - based therapy.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - gemcitabine as hydrochloride - אבקה להכנת תמיסה לאינפוזיה - gemcitabine as hydrochloride 1500 mg - gemcitabine - gemcitabine - gemcitabine is indicated for the treatment of locally advanced or metastatic bladder cancer in combination with cisplatin.gemcitabine is indicated for treatment of patients with locally advanced or metastatic adenocarcinoma of the pancreas. gemcitabine, in combination with cisplatin is indicated as first line treatment of patients with locally advanced or metastatic non-small cell lung cancer (nsclc). gemcitabine monotherapy can bee considered in elderly patients or those with performance status 2. gemcitabine is indicated for the treatment of patients with locally advanced or metastatic epithelial ovarian carcinoma, in combination with carboplatin, in patients with relapsed disease following a recurrence-free interval of at least 6 months after platinum - based, first- line therapy. gemcitabine in combination with paclitaxel, is indicated for the treatment of patients with unresectable, locally recurrent or metastatic breast cancer who have relapsed following adjuvant/neoadjuvant chemotherapy. prior chemothe

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - oxaliplatin - אבקה להכנת תמיסה לאינפוזיה - oxaliplatin 50 mg/vial - oxaliplatin - oxaliplatin - in combination with 5- fluorouracil and folinic acid (fa) oxaliplatin is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumor . treatment of metastatic colorectal cancer.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - oxaliplatin - אבקה להכנת תמיסה לאינפוזיה - oxaliplatin 100 mg/vial - oxaliplatin - oxaliplatin - in combination with 5- fluorouracil and folinic acid (fa) oxaliplatin is indicated for: adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumor . treatment of metastatic colorectal cancer.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - oxaliplatin - אבקה להכנת תמיסה לאינפוזיה - oxaliplatin 150 mg/vial - oxaliplatin - oxaliplatin - oxaliplatin in combination with 5-fluorouracil (5-fu) and folinic acid (fa) is indicated for : - adjuvant treatment of stage iii (duke's c) colon cancer after complete resection of primary tumor. - treatment on metastatic colateral cancer.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - 5-aminolevulinic acid as hydrochloride - אבקה להכנת תמיסה - 5-aminolevulinic acid as hydrochloride 1.5 g - aminolevulinic acid - aminolevulinic acid - gliolan® is indicated in adult patients for visualisation of malignant tissue during surgery for malignant glioma (who grade iii and iv).

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - tretinoin - קפסולות - tretinoin 10 mg - tretinoin - tretinoin - induction of remission in acute promyelocytic leukemia.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - clonazepam - טיפות - clonazepam 2.5 mg/ml - clonazepam - clonazepam - anti-epileptic. panic disorder.

Izraelis - hebrajų - Ministry of Health

tzamal bio-pharma ltd - clomipramine hydrochloride - טבליות בשחרור איטי - clomipramine hydrochloride 75 mg - clomipramine - clomipramine - depression of varying origin: in children and adolescents there is not sufficient evidence of safety and efficacy of anafranil in the treatment of depressive states of varying aetiology and symptomatology. the use of anafranil in children and odolescents ( 0 - 17 years of age ) in this indication is therefore not recommended. obsessive compulcive syndromes: no experience is available in children younger than 5 years of age.